Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making

Article

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).

DCIS, often considered stage 0 breast cancer, is one step before invasive breast cancer and can be treated by radiation, drugs or mastectomy to minimize chance of recurrence. However, Van Zee emphasizes that not many women want to undergo these treatments at such an early stage.

The nomogram is a tool that patients and their health care providers can use to estimate risk of recurrence, so that appropriate treatment decisions can be made.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with brown hair and bangs, surrounded by a blue border
2 experts are featured in this series.
2 experts are featured in this series.